• CDELNs Restore Sertoli-Cell Cycling After Injury

  2026-08-25

  This preprint identifies Cistanche deserticola exosome-like nanovesicles as a potential intervention for cyclophosphamide-induced testicular injury. Its central mechanistic model links heparan sulfate proteoglycan-mediated Sertoli-cell uptake to delivery of miR159b-3p, suppression of P21, and recovery of CDK1-dependent cell-cycle activity.

• SERCA-Mediated ER Stress and HSC Mobilization

  2026-08-25

  Li et al. identify SERCA-mediated endoplasmic reticulum stress as a pharmacologically tractable regulator of hematopoietic stem cell mobilization. Using BHQ, in vivo mobilization assays, cellular phenotyping, gene knockdown, and molecular analyses, the study links SERCA inhibition to the CaMKII-STAT3-CXCR4 axis and reduced surface CXCR4 on HSCs.

• TRPV1+ Nerves Suppress Inflammation via Reflex

  2026-08-24

  Song et al. identify a somato-autonomic reflex in which targeted stimulation of TRPV1+ peripheral sensory nerves activates brainstem and autonomic pathways that rapidly restrain systemic inflammation. The study connects sensory-neural input with corticosterone, catecholamine, vagal, splenic, and transcriptional responses, providing a mechanistic framework for neuroimmune intervention studies.

• Q-VD(OMe)-OPh: Workflow for Cell-Death Assays

  2026-08-23

  Q-VD(OMe)-OPh provides a low-cytotoxicity way to test whether caspase activity contributes to drug-induced cell death. This practical guide applies it to cetuximab-resistance studies, multimodal death assays, AML differentiation models, and neuroprotection workflows while emphasizing controls and interpretation limits.

• Otilonium Bromide: Assay Design Beyond Blockade

  2026-08-22

  Otilonium Bromide is an antimuscarinic agent for probing cholinergic signaling, smooth muscle function, and receptor-linked phenotypes. This guide adds a distinct evidence framework that connects practical assay design with lessons from structure-based inhibitor screening without overstating antiviral relevance.

• Escitalopram: From 5-HTT Mechanism to Translation

  2026-08-21

  A translational framework for using Escitalopram and Lexapro as selective serotonergic reference tools, connecting 5-HTT pharmacology with assay design, antidepressant research, anxiolytic activity studies, and clinically relevant interpretation.

• Dibutyryl-cAMP: A Translational Signal Strategy

  2026-08-21

  Dibutyryl-cAMP, sodium salt offers translational researchers a controllable way to interrogate cAMP–PKA signaling alongside the PTBP2–RBFOX3 splicing program that governs fibroblast-to-neuron conversion. This article separates established evidence from testable hypotheses and outlines an assay strategy for connecting pathway activation with cell-fate outcomes.

• α2-Adrenergic Modulation of Equine Airway Contraction

  2026-08-20

  This study used isolated distal bronchial rings from healthy horses to distinguish direct airway smooth-muscle activation from nerve-mediated cholinergic contraction. Clonidine and xylazine selectively reduced electrical field stimulation responses, while tolazoline prevented that inhibition, supporting a presynaptic α2-adrenergic mechanism that limits acetylcholine release.

• Tolazoline Workflows for Airway and Islet Studies

  2026-08-20

  Tolazoline enables mechanistic separation of presynaptic α2-adrenergic effects from direct airway smooth muscle contraction while also supporting concentration-controlled islet function research. This guide translates reference findings into practical workflows, controls, troubleshooting steps, and assay choices.

• 2-APB: A Temporal Probe of ER Calcium and Cell Fate

  2026-08-19

  Explore how 2-APB (2-aminoethoxydiphenyl borate) can distinguish ER calcium release, SOCE, and stress-induced cell-fate transitions. This article translates new Bombyx mori findings into a mechanism-driven assay strategy.

• Epacadostat (INCB024360) Assay Workflow Guide

  2026-08-19

  Learn how to connect Epacadostat potency with IDO1-dependent tryptophan metabolism, cytokine release, and immune-cell function. This workflow emphasizes standardized whole-blood testing, orthogonal controls, and careful interpretation of PD-1/PD-L1 checkpoint inhibitor combination data.

• Tolazoline: An Assay-Interpretation Framework

  2026-08-18

  Tolazoline is an α2-adrenergic receptor antagonist with concentration-dependent effects on KATP channels, airway tone, and insulin secretion. This guide develops an assay-interpretation framework that separates receptor pharmacology from downstream metabolic and respiratory readouts.

• Propranolol Workflows for Cardiovascular Research

  2026-08-18

  Build reproducible assays around Propranolol, a non-selective β-adrenergic receptor blocker, with practical guidance for receptor, cardiovascular, memory, and metabolic studies. The workflow connects solvent handling, dose-response design, functional readouts, and troubleshooting without treating clinical dosing as a substitute for experimental optimization.

• Avian Hair Cell Regeneration: A Multiplexed Protocol

  2026-08-17

  Sato and colleagues present an integrated protocol for inducing auditory hair-cell loss in living chickens and analyzing subsequent molecular and cellular responses. The workflow combines lateral semicircular canal sisomicin delivery, vibratome sectioning, multiplexed mRNA detection, immunohistochemistry, and EdU-based S-phase labeling, providing a reproducible platform for studying avian inner-ear regeneration.

• Tetracycline Hydrochloride: Assay Design

  2026-08-16

  Tetracycline Hydrochloride is more than a routine bacteriostatic antibiotic: it is a useful perturbation for separating bacterial growth arrest from cell killing. This guide links ribosome-centered assay design with a critical comparison to rapid ROS-driven cytotoxicity research.

454 records 7/31 page Previous Next First page 上5页 678910 下5页 Last page